APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vinpocetine

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).

Selected research

Market Outlook & Growth Opportunities

Global Vinpocetine Market Outlook and Growth Opportunities 2026

25 December 2025199 pages

Choose your research edition.

Industry ResearchVinpocetine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Vinpocetine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Vinpocetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vinpocetine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Vinpocetine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).

In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.

Read the full market overview

This report provides an overview of the global Vinpocetine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vinpocetine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vinpocetine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vinpocetine market size, projected growth trends, production technologies, key applications, and end-use industries.

Vinpocetine Segment by Company

Gedeon Richter

Runhong

Sun Pharma

WZT

PUDE

Welman

ZhiTong

Liaoning Zhiying

COVEX

Northeast Pharma

Micro Labs

Vinpocetine Segment by Type

Tablet

Injection

Vinpocetine Segment by Application

Household

Hospital

Vinpocetine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vinpocetine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vinpocetine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vinpocetine significant trends, drivers, influence factors in global and regions.

6. To analyze Vinpocetine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinpocetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vinpocetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinpocetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vinpocetine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vinpocetine industry.

Chapter 3: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vinpocetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vinpocetine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vinpocetine Industry Trends Table 2. Vinpocetine Industry Drivers Table 3. Vinpocetine Industry Opportunities and Challenges Table 4. Vinpocetine Industry Restraints Table 5. Global Vinpocetine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vinpocetine Revenue Share by Company (2021-2026) Table 7. Global Vinpocetine Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Vinpocetine Sales Volume Share by Company (2021-2026) Table 9. Global Vinpocetine Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Vinpocetine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vinpocetine Key Company Manufacturing Base & Headquarters Table 12. Global Vinpocetine Company, Product Type & Application Table 13. Global Vinpocetine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vinpocetine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Injection Table 19. Global Vinpocetine Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Vinpocetine Sales Volume by Type (2021-2026) & (M Units) Table 21. Global Vinpocetine Sales Volume by Type (2027-2032) & (M Units) Table 22. Global Vinpocetine Sales Volume Share by Type (2021-2026) Table 23. Global Vinpocetine Sales Volume Share by Type (2027-2032) Table 24. Global Vinpocetine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Vinpocetine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Vinpocetine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Vinpocetine Sales Value Share by Type (2021-2026) Table 28. Global Vinpocetine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Household Table 30. Significant Companies of Hospital Table 31. Global Vinpocetine Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Vinpocetine Sales Volume by Application (2021-2026) & (M Units) Table 33. Global Vinpocetine Sales Volume by Application (2027-2032) & (M Units) Table 34. Global Vinpocetine Sales Volume Share by Application (2021-2026) Table 35. Global Vinpocetine Sales Volume Share by Application (2027-2032) Table 36. Global Vinpocetine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Vinpocetine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Vinpocetine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Vinpocetine Sales Value Share by Application (2021-2026) Table 40. Global Vinpocetine Sales Value Share by Application (2027-2032) Table 41. Global Vinpocetine Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Vinpocetine Sales by Region (2021-2026) & (M Units) Table 43. Global Vinpocetine Sales Market Share by Region (2021-2026) Table 44. Global Vinpocetine Sales by Region (2027-2032) & (M Units) Table 45. Global Vinpocetine Sales Market Share by Region (2027-2032) Table 46. Global Vinpocetine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Vinpocetine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Vinpocetine Sales Value Share by Region (2021-2026) Table 49. Global Vinpocetine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Vinpocetine Sales Value Share by Region (2027-2032) Table 51. Global Vinpocetine Market Average Price (USD/Unit) by Region (2021-2026) Table 52. Global Vinpocetine Market Average Price (USD/Unit) by Region (2027-2032) Table 53. Global Vinpocetine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 54. Global Vinpocetine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Vinpocetine Sales by Country (2021-2026) & (M Units) Table 56. Global Vinpocetine Sales Market Share by Country (2021-2026) Table 57. Global Vinpocetine Sales by Country (2027-2032) & (M Units) Table 58. Global Vinpocetine Sales Market Share by Country (2027-2032) Table 59. Global Vinpocetine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Vinpocetine Sales Value Market Share by Country (2021-2026) Table 61. Global Vinpocetine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Vinpocetine Sales Value Market Share by Country (2027-2032) Table 63. Gedeon Richter Company Information Table 64. Gedeon Richter Business Overview Table 65. Gedeon Richter Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Gedeon Richter Vinpocetine Product Portfolio Table 67. Gedeon Richter Recent Development Table 68. Runhong Company Information Table 69. Runhong Business Overview Table 70. Runhong Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Runhong Vinpocetine Product Portfolio Table 72. Runhong Recent Development Table 73. Sun Pharma Company Information Table 74. Sun Pharma Business Overview Table 75. Sun Pharma Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Sun Pharma Vinpocetine Product Portfolio Table 77. Sun Pharma Recent Development Table 78. WZT Company Information Table 79. WZT Business Overview Table 80. WZT Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. WZT Vinpocetine Product Portfolio Table 82. WZT Recent Development Table 83. PUDE Company Information Table 84. PUDE Business Overview Table 85. PUDE Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. PUDE Vinpocetine Product Portfolio Table 87. PUDE Recent Development Table 88. Welman Company Information Table 89. Welman Business Overview Table 90. Welman Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Welman Vinpocetine Product Portfolio Table 92. Welman Recent Development Table 93. ZhiTong Company Information Table 94. ZhiTong Business Overview Table 95. ZhiTong Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. ZhiTong Vinpocetine Product Portfolio Table 97. ZhiTong Recent Development Table 98. Liaoning Zhiying Company Information Table 99. Liaoning Zhiying Business Overview Table 100. Liaoning Zhiying Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Liaoning Zhiying Vinpocetine Product Portfolio Table 102. Liaoning Zhiying Recent Development Table 103. COVEX Company Information Table 104. COVEX Business Overview Table 105. COVEX Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. COVEX Vinpocetine Product Portfolio Table 107. COVEX Recent Development Table 108. Northeast Pharma Company Information Table 109. Northeast Pharma Business Overview Table 110. Northeast Pharma Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Northeast Pharma Vinpocetine Product Portfolio Table 112. Northeast Pharma Recent Development Table 113. Micro Labs Company Information Table 114. Micro Labs Business Overview Table 115. Micro Labs Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Micro Labs Vinpocetine Product Portfolio Table 117. Micro Labs Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Vinpocetine Distributors List Table 121. Vinpocetine Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Vinpocetine Product Image Figure 2. Global Vinpocetine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vinpocetine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vinpocetine Sales (2021-2032) & (M Units) Figure 5. Global Vinpocetine Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Vinpocetine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Injection Image Figure 11. Global Vinpocetine Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Vinpocetine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Vinpocetine Sales Volume Share by Type (2021-2032) Figure 14. Global Vinpocetine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Vinpocetine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Vinpocetine Sales Value Share by Type (2021-2032) Figure 17. Household Image Figure 18. Hospital Image Figure 19. Global Vinpocetine Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Vinpocetine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Vinpocetine Sales Volume Share by Application (2021-2032) Figure 22. Global Vinpocetine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Vinpocetine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Vinpocetine Sales Value Share by Application (2021-2032) Figure 25. Global Vinpocetine Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 26. Global Vinpocetine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Vinpocetine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Vinpocetine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Vinpocetine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Vinpocetine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Vinpocetine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Vinpocetine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Vinpocetine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Vinpocetine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Vinpocetine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Vinpocetine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Vinpocetine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Vinpocetine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Vinpocetine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Vinpocetine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Vinpocetine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Vinpocetine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Vinpocetine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Injection
Applications
  • Household
  • Hospital
Companies covered
  • Gedeon Richter
  • Runhong
  • Sun Pharma
  • WZT
  • PUDE
  • Welman
  • ZhiTong
  • Liaoning Zhiying
  • COVEX
  • Northeast Pharma
  • Micro Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vinpocetine Sales Value (2021-2032)
  4. 1.2.2 Global Vinpocetine Sales Volume (2021-2032)
  5. 1.2.3 Global Vinpocetine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vinpocetine Market Dynamics
  1. 2.1 Vinpocetine Industry Trends
  2. 2.2 Vinpocetine Industry Drivers
  3. 2.3 Vinpocetine Industry Opportunities and Challenges
  4. 2.4 Vinpocetine Industry Restraints
3 Vinpocetine Market by Company
  1. 3.1 Global Vinpocetine Company Revenue Ranking in 2025
  2. 3.2 Global Vinpocetine Revenue by Company (2021-2026)
  3. 3.3 Global Vinpocetine Sales Volume by Company (2021-2026)
  4. 3.4 Global Vinpocetine Average Price by Company (2021-2026)
  5. 3.5 Global Vinpocetine Company Ranking (2024-2026)
  6. 3.6 Global Vinpocetine Company Manufacturing Base and Headquarters
  7. 3.7 Global Vinpocetine Company Product Type and Application
  8. 3.8 Global Vinpocetine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vinpocetine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vinpocetine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vinpocetine Market by Type
  1. 4.1 Vinpocetine Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Injection
  4. 4.2 Global Vinpocetine Sales Volume by Type
  5. 4.2.1 Global Vinpocetine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Vinpocetine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Vinpocetine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Vinpocetine Sales Value by Type
  9. 4.3.1 Global Vinpocetine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Vinpocetine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Vinpocetine Sales Value Share by Type (2021-2032)
5 Vinpocetine Market by Application
  1. 5.1 Vinpocetine Application Introduction
  2. 5.1.1 Household
  3. 5.1.2 Hospital
  4. 5.2 Global Vinpocetine Sales Volume by Application
  5. 5.2.1 Global Vinpocetine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Vinpocetine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Vinpocetine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Vinpocetine Sales Value by Application
  9. 5.3.1 Global Vinpocetine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Vinpocetine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Vinpocetine Sales Value Share by Application (2021-2032)
6 Vinpocetine Regional Sales and Value Analysis
  1. 6.1 Global Vinpocetine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vinpocetine Sales by Region (2021-2032)
  3. 6.2.1 Global Vinpocetine Sales by Region: 2021-2026
  4. 6.2.2 Global Vinpocetine Sales by Region (2027-2032)
  5. 6.3 Global Vinpocetine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vinpocetine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vinpocetine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vinpocetine Sales Value by Region (2027-2032)
  9. 6.5 Global Vinpocetine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vinpocetine Sales Value (2021-2032)
  12. 6.6.2 North America Vinpocetine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vinpocetine Sales Value (2021-2032)
  15. 6.7.2 Europe Vinpocetine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vinpocetine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vinpocetine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vinpocetine Sales Value (2021-2032)
  21. 6.9.2 South America Vinpocetine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vinpocetine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vinpocetine Sales Value Share by Country, 2025 VS 2032
7 Vinpocetine Country-level Sales and Value Analysis
  1. 7.1 Global Vinpocetine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vinpocetine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vinpocetine Sales by Country (2021-2032)
  4. 7.3.1 Global Vinpocetine Sales by Country (2021-2026)
  5. 7.3.2 Global Vinpocetine Sales by Country (2027-2032)
  6. 7.4 Global Vinpocetine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vinpocetine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vinpocetine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vinpocetine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vinpocetine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vinpocetine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vinpocetine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vinpocetine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vinpocetine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vinpocetine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vinpocetine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vinpocetine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vinpocetine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vinpocetine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vinpocetine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vinpocetine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vinpocetine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vinpocetine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vinpocetine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vinpocetine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vinpocetine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vinpocetine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vinpocetine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vinpocetine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vinpocetine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vinpocetine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vinpocetine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vinpocetine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vinpocetine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vinpocetine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vinpocetine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vinpocetine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vinpocetine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vinpocetine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vinpocetine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vinpocetine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vinpocetine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vinpocetine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vinpocetine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vinpocetine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vinpocetine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vinpocetine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vinpocetine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vinpocetine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vinpocetine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vinpocetine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vinpocetine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vinpocetine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vinpocetine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vinpocetine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vinpocetine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vinpocetine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vinpocetine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vinpocetine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vinpocetine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vinpocetine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vinpocetine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vinpocetine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vinpocetine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vinpocetine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vinpocetine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vinpocetine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vinpocetine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vinpocetine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vinpocetine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vinpocetine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vinpocetine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vinpocetine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vinpocetine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vinpocetine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vinpocetine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vinpocetine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vinpocetine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vinpocetine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vinpocetine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vinpocetine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vinpocetine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vinpocetine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vinpocetine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vinpocetine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vinpocetine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vinpocetine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vinpocetine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vinpocetine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vinpocetine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vinpocetine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vinpocetine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Gedeon Richter
  2. 8.1.1 Gedeon Richter Company Information
  3. 8.1.2 Gedeon Richter Business Overview
  4. 8.1.3 Gedeon Richter Vinpocetine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Gedeon Richter Vinpocetine Product Portfolio
  6. 8.1.5 Gedeon Richter Recent Developments
  7. 8.2 Runhong
  8. 8.2.1 Runhong Company Information
  9. 8.2.2 Runhong Business Overview
  10. 8.2.3 Runhong Vinpocetine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Runhong Vinpocetine Product Portfolio
  12. 8.2.5 Runhong Recent Developments
  13. 8.3 Sun Pharma
  14. 8.3.1 Sun Pharma Company Information
  15. 8.3.2 Sun Pharma Business Overview
  16. 8.3.3 Sun Pharma Vinpocetine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharma Vinpocetine Product Portfolio
  18. 8.3.5 Sun Pharma Recent Developments
  19. 8.4 WZT
  20. 8.4.1 WZT Company Information
  21. 8.4.2 WZT Business Overview
  22. 8.4.3 WZT Vinpocetine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 WZT Vinpocetine Product Portfolio
  24. 8.4.5 WZT Recent Developments
  25. 8.5 PUDE
  26. 8.5.1 PUDE Company Information
  27. 8.5.2 PUDE Business Overview
  28. 8.5.3 PUDE Vinpocetine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 PUDE Vinpocetine Product Portfolio
  30. 8.5.5 PUDE Recent Developments
  31. 8.6 Welman
  32. 8.6.1 Welman Company Information
  33. 8.6.2 Welman Business Overview
  34. 8.6.3 Welman Vinpocetine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Welman Vinpocetine Product Portfolio
  36. 8.6.5 Welman Recent Developments
  37. 8.7 ZhiTong
  38. 8.7.1 ZhiTong Company Information
  39. 8.7.2 ZhiTong Business Overview
  40. 8.7.3 ZhiTong Vinpocetine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ZhiTong Vinpocetine Product Portfolio
  42. 8.7.5 ZhiTong Recent Developments
  43. 8.8 Liaoning Zhiying
  44. 8.8.1 Liaoning Zhiying Company Information
  45. 8.8.2 Liaoning Zhiying Business Overview
  46. 8.8.3 Liaoning Zhiying Vinpocetine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Liaoning Zhiying Vinpocetine Product Portfolio
  48. 8.8.5 Liaoning Zhiying Recent Developments
  49. 8.9 COVEX
  50. 8.9.1 COVEX Company Information
  51. 8.9.2 COVEX Business Overview
  52. 8.9.3 COVEX Vinpocetine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 COVEX Vinpocetine Product Portfolio
  54. 8.9.5 COVEX Recent Developments
  55. 8.10 Northeast Pharma
  56. 8.10.1 Northeast Pharma Company Information
  57. 8.10.2 Northeast Pharma Business Overview
  58. 8.10.3 Northeast Pharma Vinpocetine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Northeast Pharma Vinpocetine Product Portfolio
  60. 8.10.5 Northeast Pharma Recent Developments
  61. 8.11 Micro Labs
  62. 8.11.1 Micro Labs Company Information
  63. 8.11.2 Micro Labs Business Overview
  64. 8.11.3 Micro Labs Vinpocetine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Micro Labs Vinpocetine Product Portfolio
  66. 8.11.5 Micro Labs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vinpocetine Value Chain Analysis
  2. 9.1.1 Vinpocetine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vinpocetine Sales Mode & Process
  6. 9.2 Vinpocetine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vinpocetine Distributors
  9. 9.2.3 Vinpocetine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst